These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 37336336)

  • 1. Erchen Decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid β-oxidation.
    Zhang L; Chen N; Zhan L; Bi T; Zhou W; Zhang L; Zhu L
    J Ethnopharmacol; 2023 Dec; 317():116811. PubMed ID: 37336336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease.
    Liu H; Xu J; Li H; Zhang L; Xu P
    Anat Rec (Hoboken); 2021 Nov; 304(11):2605-2619. PubMed ID: 34536264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis.
    Shashni B; Tajika Y; Ikeda Y; Nishikawa Y; Nagasaki Y
    Biomaterials; 2023 Apr; 295():122047. PubMed ID: 36840994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat diet-induced gut microbiota alteration promotes lipogenesis by butyric acid/miR-204/ACSS2 axis in chickens.
    Chen C; Chen W; Ding H; Wu P; Zhang G; Xie K; Zhang T
    Poult Sci; 2023 Sep; 102(9):102856. PubMed ID: 37390560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
    Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
    Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
    de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
    Front Immunol; 2019; 10():2926. PubMed ID: 31998283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with Sodium Butyrate Modulates the Composition of the Gut Microbiota and Ameliorates High-Fat Diet-Induced Obesity in Mice.
    Fang W; Xue H; Chen X; Chen K; Ling W
    J Nutr; 2019 May; 149(5):747-754. PubMed ID: 31004166
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wang B; Kong Q; Cui S; Li X; Gu Z; Zhao J; Zhang H; Chen W; Wang G
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801119
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sun Y; Liu X; Wang R; Liu R; Lv X; Ma Y; Li Q
    Food Funct; 2024 Apr; 15(8):4475-4489. PubMed ID: 38563737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
    Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
    Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary Fiber in Bilberry Ameliorates Pre-Obesity Events in Rats by Regulating Lipid Depot, Cecal Short-Chain Fatty Acid Formation and Microbiota Composition.
    Liu HY; Walden TB; Cai D; Ahl D; Bertilsson S; Phillipson M; Nyman M; Holm L
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31208043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zanthoxylum bungeanum amides ameliorates nonalcoholic fatty liver via regulating gut microbiota and activating AMPK/Nrf2 signaling.
    Peng W; He CX; Li RL; Qian D; Wang LY; Chen WW; Zhang Q; Wu CJ
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116848. PubMed ID: 37423515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
    Lee JE; Lee SM; Jung J
    Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A High-Fat Diet Increases Gut Microbiota Biodiversity and Energy Expenditure Due to Nutrient Difference.
    Wang B; Kong Q; Li X; Zhao J; Zhang H; Chen W; Wang G
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erchen decoction alleviates the progression of NAFLD by inhibiting lipid accumulation and iron overload through Caveolin-1 signaling.
    Deng G; Li J; Huang M; Li Y; Shi H; Wu C; Zhao J; Qin M; Liu C; Yang M; Wang Y; Zhang Y; Liao Y; Zhou C; Yang J; Xu Y; Liu B; Gao L
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117320. PubMed ID: 37838297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice.
    Li S; You J; Wang Z; Liu Y; Wang B; Du M; Zou T
    Food Res Int; 2021 May; 143():110270. PubMed ID: 33992371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New strain of
    Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
    World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysaccharide-rich fractions from Enteromorpha prolifera improve hepatic steatosis and gut barrier integrity in high-fat diet-induced obese mice linking to modulation of gut microbiota.
    Zou T; Xie F; Liang P; Chen J; Wang Z; Du M; You J
    Biomed Pharmacother; 2023 Jan; 157():114034. PubMed ID: 36434956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.